Search Results - "Borg, C."

Selecting the right chemotherapy in first-line advanced squamous cell carcinoma of the anus by Ducreux, M., Kim, S., Borg, C.

Get full text

3D Printing Concrete on temporary surfaces: The design and fabrication of a concrete shell structure by Borg Costanzi, C., Ahmed, Z.Y., Schipper, H.R., Bos, F.P., Knaack, U., Wolfs, R.J.M.

“…One of the geometrical restrictions associated with printed paste materials such as concrete, is that material must be self-supporting during printing. In this…”
Get full text

Clinical utility of circulating DNA analysis for rapid detection of actionable mutations to select metastatic colorectal patients for anti-EGFR treatment by Thierry, A.R., El Messaoudi, S., Mollevi, C., Raoul, J.L., Guimbaud, R., Pezet, D., Artru, P., Assenat, E., Borg, C., Mathonnet, M., De La Fouchardière, C., Bouché, O., Gavoille, C., Fiess, C., Auzemery, B., Meddeb, R., Lopez-Crapez, E., Sanchez, C., Pastor, B., Ychou, M.

“…While tumor-tissue remains the ‘gold standard’ for genetic analysis in cancer patients, it is challenged with the advent of circulating cell-free tumor DNA…”
Get full text

PD-L1 expression is regulated by both DNA methylation and NF-kB during EMT signaling in non-small cell lung carcinoma by Asgarova, A., Asgarov, K., Godet, Y., Peixoto, P., Nadaradjane, A., Boyer-Guittaut, M., Galaine, J., Guenat, D., Mougey, V., Perrard, J., Pallandre, J. R., Bouard, A., Balland, J., Tirole, C., Adotevi, O., Hendrick, E., Herfs, M., Cartron, P. F., Borg, C., Hervouet, E.

“…Tumor cells, which undergo Epithelial-mesenchymal transition (EMT) acquire increased capacities of proliferation, invasion and have the ability to generate…”
Get full text

Prognostic and predictive value of the Immunoscore in stage III colon cancer patients treated with oxaliplatin in the prospective IDEA France PRODIGE-GERCOR cohort study by Pagès, F, André, T, Taieb, J, Vernerey, D, Henriques, J, Borg, C, Marliot, F, Ben Jannet, R, Louvet, C, Mineur, L, Bennouna, J, Desrame, J, Faroux, R, Kirilovsky, A, Duval, A, Laurent-Puig, P, Svrcek, M, Hermitte, F, Catteau, A, Galon, J, Emile, J-F

“…The Immunoscore (IS), which prognostically classifies stage I-III colon cancer (CC) patients, was evaluated in the International Duration Evaluation of…”
Get full text

Age‐related differences in self‐reported disgust toward core disgust, sex‐related, and food stimuli by Oosterwijk, T. A. (Tamara), Borg, C. (Charmaine), Dijk, M. W. G. (Marijn)

“…Introduction While disgust is functional in preventing contagion from pathogens, it also plays a role in various psychopathologies. Disgust responses…”
Get full text

Progressive rise in gut hormone levels after Roux-en-Y gastric bypass suggests gut adaptation and explains altered satiety by Borg, C. M., le Roux, C. W., Ghatei, M. A., Bloom, S. R., Patel, A. G., Aylwin, S. J. B.

“…Background: Bariatric surgery is the most effective treatment for achieving long‐term weight loss in morbidly obese patients. This study investigated…”
Get full text

Attenuated Peptide YY Release in Obese Subjects Is Associated with Reduced Satiety by le Roux, C. W, Batterham, R. L, Aylwin, S. J. B, Patterson, M, Borg, C. M, Wynne, K. J, Kent, A, Vincent, R. P, Gardiner, J, Ghatei, M. A, Bloom, S. R

“…The responses of the gut hormone peptide YY (PYY) to food were investigated in 20 normal-weight and 20 obese humans in response to six test meals of varying…”
Get full text

Spontaneous sensations reveal distorted body perception in complex regional pain syndrome (CRPS) by Echalier, A., Borg, C., Creac'h, C., Laurent, B., Michael, G.A.

“…•Body representation distrotions have been reported in the CRPS.•Spontaneous sensations (SPS) were used to investigate such disturbances.•Ipsilateral and…”
Get full text

Trifluridine/tipiracil plus bevacizumab in patients with untreated metastatic colorectal cancer ineligible for intensive therapy: the randomized TASCO1 study by Van Cutsem, E., Danielewicz, I., Saunders, M.P., Pfeiffer, P., Argilés, G., Borg, C., Glynne-Jones, R., Punt, C.J.A., Van de Wouw, A.J., Fedyanin, M., Stroyakovskiy, D., Kroening, H., Garcia-Alfonso, P., Wasan, H., Falcone, A., Kanehisa, A., Egorov, A., Aubel, P., Amellal, N., Moiseenko, V.

“…We designed an open-label, noncomparative phase II study to assess the safety and efficacy of first-line treatment with trifluridine/tipiracil plus bevacizumab…”
Get full text

The presence of senescent peripheral T-cells is negatively correlated to COVID-19 vaccine-induced immunity in cancer patients under 70 years of age by Orillard, E, Spehner, L, Mansi, L, Bouard, A, Falcoz, A, Lepiller, Q, Renaude, E, Pallandre, J R, Vienot, A, Kroemer, M, Borg, C

“…Cancer patients are at risk of severe COVID-19 infection, and vaccination is recommended. Nevertheless, we observe a failure of COVID-19 vaccines in this…”
Get full text

Impact of the COVID-19 pandemic on gastrointestinal endoscopy in the Netherlands: analysis of a prospective endoscopy database by Lantinga, Marten A, Theunissen, Felix, Ter Borg, Pieter C J, Bruno, Marco J, Ouwendijk, Rob J T, Siersema, Peter D

“…COVID-19 has dramatically affected gastrointestinal endoscopy practice. We aimed to investigate its impact on procedure types, indications, and findings.  We…”
Get more information

First-line trifluridine/tipiracil + bevacizumab in patients with unresectable metastatic colorectal cancer: final survival analysis in the TASCO1 study by Van Cutsem, E., Danielewicz, I., Saunders, M. P., Pfeiffer, P., Argilés, G., Borg, C., Glynne-Jones, R., Punt, C. J. A., Van de Wouw, A. J., Fedyanin, M., Stroyakovskiy, D., Kroening, H., Garcia-Alfonso, P., Wasan, H., Falcone, A., Fougeray, R., Egorov, A., Amellal, N., Moiseyenko, V.

“…Background Therapeutic options are limited in patients with unresectable metastatic colorectal cancer (mCRC) ineligible for intensive chemotherapy. The use of…”
Get full text

Tumor lymphocyte immune response to preoperative radiotherapy in locally advanced rectal cancer: The LYMPHOREC study by Mirjolet, C., Charon-Barra, C., Ladoire, S., Arbez-Gindre, F., Bertaut, A., Ghiringhelli, F., Leroux, A., Peiffert, D., Borg, C., Bosset, J. F., Créhange, G.

“…Introduction: Some studies have suggested that baseline tumor-infiltrating-lymphocytes (TILs), such as CD8+ and FoxP3+ T-cells, may be associated with a better…”
Get full text

Visceral fat area is an independent predictive biomarker of outcome after first-line bevacizumab-based treatment in metastatic colorectal cancer by Guiu, Boris, Petit, Jean Michel, Bonnetain, Franck, Ladoire, Sylvain, Guiu, Séverine, Cercueil, Jean-Pierre, Krausé, Denis, Hillon, Patrick, Borg, Christophe, Chauffert, Bruno, Ghiringhelli, François

“…Adipose tissue releases angiogenic factors that may promote tumour growth. To determine whether body mass index (BMI), subcutaneous fat area (SFA) and visceral…”
Get more information

Prevalence, distribution and amplitude of the complement interference phenomenon in single antigen flow beads assays by Guidicelli, G., Visentin, J., Franchini, N., Borg, C., Merville, P., Couzi, L., Taupin, J.‐L.

“…HLA antibody detection with single antigen flow beads (SAFB) assays is impaired by complement interference whose frequency, predictability and distribution…”
Get full text

Does an observer's empathy influence my pain? Effect of perceived empathetic or unempathetic support on a pain test by Fauchon, C., Faillenot, I., Perrin, A. M., Borg, C., Pichot, V., Chouchou, F., Garcia‐Larrea, L., Peyron, R.

“…The physiological and behavioural effects of empathy for other's pain have been widely investigated, while the opposite situation, i.e. the influence on one's…”
Get full text

Endpoints in cancer clinical trials by Fiteni, F, Westeel, V, Pivot, X, Borg, C, Vernerey, D, Bonnetain, F

“…Summary Endpoints are measurable clinical and biological findings that are used for the development and assessment of treatment options. In the treatment of…”
Get full text

How health-related quality of life assessment should be used in advanced colorectal cancer clinical trials by Bonnetain, F., Borg, C., Adams, R.R., Ajani, J.A., Benson, A., Bleiberg, H., Chibaudel, B., Diaz-Rubio, E., Douillard, J.Y., Fuchs, C.S., Giantonio, B.J., Goldberg, R., Heinemann, V., Koopman, M., Labianca, R., Larsen, A.K., Maughan, T., Mitchell, E., Peeters, M., Punt, C.J.A., Schmoll, H.J., Tournigand, C., de Gramont, A.

“…Traditionally, the efficacy of cancer treatment in patients with advance or metastatic disease in clinical studies has been studied using overall survival and…”
Get full text

Pathological response and safety of two neoadjuvant strategies with bevacizumab in MRI-defined locally advanced T3 resectable rectal cancer: a randomized, noncomparative phase II study by Borg, C., André, T., Mantion, G., Boudghène, F., Mornex, F., Maingon, P., Adenis, A., Azria, D., Piutti, M., Morsli, O., Bosset, J.F.

“…In T3 rectal cancer (RC), preoperative chemoradiotherapy [5-fluorouracil (5-FU–RT)] reduces local recurrences, but does not affect overall survival. New…”
Get full text